CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease

被引:13
作者
Wang, Xiangyu [1 ]
Song, Minkai [2 ]
Li, Xiaomin [1 ]
Su, Cailin [1 ]
Yang, Yanlin [1 ]
Wang, Kai [3 ]
Liu, Cuiting [4 ]
Zheng, Zongji [1 ]
Jia, Yijie [1 ]
Ren, Shijing [1 ]
Dong, Wenhui [1 ]
Chen, Jiaqi [1 ]
Wang, Ting [5 ]
Liu, Lerong [1 ]
Guan, Meiping [1 ]
Zhang, Chao [5 ]
Xue, Yaoming [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Orthopaed Surg, Guangzhou, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Div Hepatobiliopancreat Surg, Guangzhou, Peoples R China
[4] Southern Med Univ, Cent Lab, Guangzhou, Peoples R China
[5] Southern Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guangdong Prov Key Lab Single Cell Technol & Appli, Guangzhou, Peoples R China
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2023年 / 325卷 / 02期
关键词
ceramide synthase 6; diabetic kidney disease; interstitial fibrosis; mitophagy; renal tubular epithelial cell; METABOLISM; SPHINGOLIPIDS;
D O I
10.1152/ajpcell.00144.2023
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During diabetic kidney disease (DKD), ectopic ceramide (CER) accumulation in renal tubular epithelial cells (RTECs) is associated with interstitial fibrosis and albuminuria. As RTECs are primarily responsible for renal energy metabolism, their function is intimately linked to mitochondrial quality control. The role of CER synthesis in the progression of diabetic renal fibrosis has not been thoroughly investigated. In this study, we observed a significant upregulation of ceramide synthase 6 (Cers6) expression in the renal cortex of db/db mice, coinciding with increased production of CER (d18:1/14:0) and CER (d18:1/16:0) by Cer6. Concurrently, the number of damaged mitochondria in RTECs rose. Cers6 deficiency reduced the abnormal accumulation of CER (d18:1/14:0) and CER (d18:1/16:0) in the kidney cortex, restoring the PTEN-induced kinase 1 (PINK1)-mediated mitophagy in RTECs, and resulting in a decrease in damaged mitochondria and attenuation of interstitial fibrosis in DKD. Automated docking analysis suggested that both CER (d18:1/14:0) and CER (d18:1/16:0) could bind to the PINK1 protein. Furthermore, inhibiting PINK1 expression in CERS6 knockdown HK-2 cells diminished the therapeutic effect of CERS6 deficiency on DKD. In summary, CERS6-derived CER (d18:1/14:0) and CER (d18:1/16:0) inhibit PINK1-regulated mitophagy by possibly binding to the PINK1 protein, thereby exacerbating the progression of renal interstitial fibrosis in DKD.NEW & NOTEWORTHY This article addresses the roles of ceramide synthase 6 (CERS6) and CERS6-derived ceramides in renal tubular epithelial cells of diabetic kidney disease (DKD) associated interstitial fibrosis. Results from knockdown of CERS6 adjusted the ceramide pool in kidney cortex and markedly protected from diabetic-induced kidney fibrosis in vivo and in vitro. Mechanically, CERS6-derived ceramides might interact with PINK1 to inhibit PINK1/Parkin-mediated mitophagy and aggravate renal interstitial fibrosis in DKD.
引用
收藏
页码:C538 / C549
页数:12
相关论文
共 33 条
  • [1] Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases
    Bhat, Owais M.
    Yuan, Xinxu
    Li, Guangbi
    Lee, RaMi
    Li, Pin-Lan
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2018, 28 (10) : 1008 - 1026
  • [2] Ceramides in Metabolism: Key Lipotoxic Players
    Chaurasia, Bhagirath
    Summers, Scott A.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 83, 2021, 83 : 303 - 330
  • [3] Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
    Chaurasia, Bhagirath
    Tippetts, Trevor S.
    Monibas, Rafael Mayoral
    Liu, Jinqi
    Li, Ying
    Wang, Liping
    Wilkerson, Joseph L.
    Sweeney, C. Rufus
    Pereira, Renato Felipe
    Sumida, Doris Hissako
    Maschek, J. Alan
    Cox, James E.
    Kaddai, Vincent
    Lancaster, Graeme Iain
    Siddique, Monowarul Mobin
    Poss, Annelise
    Pearson, Mackenzie
    Satapati, Santhosh
    Zhou, Heather
    McLaren, David G.
    Previs, Stephen F.
    Chen, Ying
    Qian, Ying
    Petrov, Aleksandr
    Wu, Margaret
    Shen, Xiaolan
    Yao, Jun
    Nunes, Christian N.
    Howard, Andrew D.
    Wang, Liangsu
    Erion, Mark D.
    Rutter, Jared
    Holland, William L.
    Kelley, David E.
    Summers, Scott A.
    [J]. SCIENCE, 2019, 365 (6451) : 386 - +
  • [4] Ceramides - Lipotoxic Inducers of Metabolic Disorders (vol 26, pg 538, 2015)
    Chaurasia, Bhagirath
    Summers, Scott A.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (01) : 66 - 67
  • [5] Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015
    Cheng, Hui-Teng
    Xu, Xiaoqi
    Lim, Paik Seong
    Hung, Kuan-Yu
    [J]. DIABETES CARE, 2021, 44 (01) : 89 - 97
  • [6] Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
    Drexler, Yelena
    Molina, Judith
    Mitrofanova, Alla
    Fornoni, Alessia
    Merscher, Sandra
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 9 - 31
  • [7] Silymarin protects against renal injury through normalization of lipid metabolism and mitochondrial biogenesis in high fat-fed mice
    Feng, Bin
    Meng, Ran
    Huang, Bin
    Bi, Yan
    Shen, Shanmei
    Zhu, Dalong
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2017, 110 : 240 - 249
  • [8] Mitochondrial dysfunction in diabetic kidney disease
    Forbes, Josephine M.
    Thorburn, David R.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (05) : 291 - 312
  • [9] Computational protein-ligand docking and virtual drug screening with the AutoDock suite
    Forli, Stefano
    Huey, Ruth
    Pique, Michael E.
    Sanner, Michel F.
    Goodsell, David S.
    Olson, Arthur J.
    [J]. NATURE PROTOCOLS, 2016, 11 (05) : 905 - 919
  • [10] EVOLVING AND EXPANDING THE ROLES OF MITOPHAGY AS A HOMEOSTATIC AND PATHOGENIC PROCESS
    Gustafsson, Asa B.
    Dorn, Gerald W., II
    [J]. PHYSIOLOGICAL REVIEWS, 2019, 99 (01) : 853 - 892